Sight Sciences is a developer of glaucoma implants for the treatment of irreversible blindness.. Founded by David Badawi and Paul Badawi in 2010, Sight Sciences is backed by investors that include Allegro Investment Fund, Hicks Equity Partners, KCK, MidCap Financial, and Scientific Health Development Partners and is headquartered in San Francisco.